跳至主要内容
临床试验/IRCT20170917036227N5
IRCT20170917036227N5招募中3 期

Comparison of the effectiveness of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrence after laparoscopic surgery in patients with endometriosis

Tehran University of Medical Sciences0 个研究点目标入组 130 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Women aged 18-45 years old
  • Endometriosis confirmation via laparoscopy and histopathologic assessmnet

排除标准

  • Pregnancy or Breast Feeding
  • Plan to become pregnant
  • Amenorrhea (no more menstruation - equal to 3 months in the last 6 months)
  • Undiagnosed genital bleeding
  • Recent use of hormonal agents
  • Contraindications to the use of progesterone
  • Having a risk factor for decreased bone density
  • Use of acitretin, anticoagulants such as warfarin, antidiabetic drugs, aperitif and, artemether, atazanavir, barbiturates, bexarotene, Boceprevir, bosentan, thrombogenic drugs, clobazam, anticonvulsant drugs (carphenazine, Topiramate, valproic acid, lamotrigine, phenytoin ...), Darunavir, Deferasirox, Efavirenz, Felbamate, Griseofulvin, Mifepristone, Nelfinavir, Neuruppin, Selegiline, Thalidomide, Tranexamic Acid and Voriconazole

研究者

相似试验